Target Name: LOC105376270
NCBI ID: G105376270
Review Report on LOC105376270 Target / Biomarker Content of Review Report on LOC105376270 Target / Biomarker
LOC105376270
Other Name(s): uncharacterized LOC105376270 | Uncharacterized LOC105376270, transcript variant X1 | LOC105376270 variant X1

LOC105376270: A Potential Drug Target for T-Cell and Inflammation Regulation

LOC105376270 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the T-cell antigen receptor family, which is a protein that is involved in the immune response. LOC105376270 has been shown to play a role in the regulation of immune cell function and has been identified as a potential drug target.

One of the key functions of LOC105376270 is its role in the regulation of T-cell function. T-cells are a type of immune cell that play a critical role in the immune response by producing antibodies that help to neutralize foreign substances in the body. LOC105376270 has been shown to help regulate the number and function of T-cells, which is important for maintaining a healthy immune system.

Another function of LOC105376270 is its role in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection, but chronic inflammation can lead to a range of diseases, including heart disease and diabetes. LOC105376270 has been shown to help regulate the production of pro-inflammatory cytokines, which are important for initiating and sustaining inflammation.

In addition to its role in T-cell and inflammation regulation, LOC105376270 has also been shown to play a role in the regulation of cell survival. Prolonged exposure to stress and environmental factors can lead to increased cell death, which can have a negative impact on the immune system and contribute to the development of diseases such as cancer. LOC105376270 has been shown to help regulate cell survival by preventing the formation of apoptotic cells.

The potential implications of LOC105376270 as a drug target are significant. If LOC105376270 can be effectively targeted by drugs, it may be possible to treat a range of diseases that are currently treated with drugs that have limited efficacy. For example, LOC105376270 has been shown to be involved in the regulation of T-cell function, which is a critical factor in the development of many immunodeficient diseases. If LOC105376270 can be effectively targeted by drugs, it may be possible to treat diseases such as autoimmune disorders, in which the immune system attacks the body's own tissues.

LOC105376270 has also been shown to play a role in the regulation of inflammation, which is a critical factor in the development of many chronic diseases. Chronic inflammation can lead to the formation of pro-inflammatory cytokines, which can contribute to the development of diseases such as heart disease and diabetes. If LOC105376270 can be effectively targeted by drugs, it may be possible to treat chronic inflammatory diseases with drugs that have been shown to be effective in treating other types of inflammation.

In addition to its potential as a drug target, LOC105376270 has also been shown to play a role in the regulation of cell survival. Prolonged exposure to stress and environmental factors can lead to increased cell death, which can have a negative impact on the immune system and contribute to the development of diseases such as cancer. If LOC105376270 can be effectively targeted by drugs, it may be possible to treat many types of cancer with drugs that have been shown to be effective in treating

Protein Name: Uncharacterized LOC105376270

The "LOC105376270 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376270 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313